
|Articles|December 1, 2004
New AK therapies offer tx choices
National Report - With the rapid onset of new therapies available for the treatment of actinic keratosis (AK), Stacy Smith, M.D. of Therapeutics Clinical Research in California, has demonstrated that efficacy, tolerability and cost play a combined role in the approach used to treat AK.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
4
Meta-analysis Confirms Benefits of Roflumilast 0.3% Cream for PsO
5


















